Familial adenomatous polyposis: the practical applications of clinical and molecular screening
Authors:
- 1 September 2006
- journal article
- review article
- Published by Springer Nature in Familial Cancer
- Vol. 5 (3) , 227-235
Abstract
Familial adenomatous polyposis (FAP) is an autosomal dominant condition mostly due to a mutation of the APC gene on the chromosome 5q. Carriers have an almost 100% chance of developing colorectal cancer after having multiple (typically 100s to 1000s) of adenomatous polyps. It is usually readily identified through this phenotype of multiple adenomas. Correlations between the location of the family-specific mutation on the APC gene and clinical manifestations of the disease are of some assistance in clinical management, though there is heterogeneity in clinical course even between family members with the same mutation. FAP is important to recognize, as there are diseasespecific management implications with respect to offering mutational analysis of the APC (and perhaps other) genes for predictive testing of other family members, endoscopic diagnostic procedures, surveillance planning, and surgical management. Extra-colonic manifestations, including duodenal polyposis, desmoid disease and other tumours, can dominate clinical care after colectomy. The inheritable and lethal nature of the disease, together with the availability of effective treatment strategies, makes a sensitive clinical and psychosocial approach important to maximize compliance and good outcomes for all members of affected families.Keywords
This publication has 59 references indexed in Scilit:
- Duodenal adenomatosis in familial adenomatous polyposisGut, 2004
- An Ancestral Ashkenazi Haplotype at the HMPS/CRAC1 Locus on 15q13–q14 Is Associated with Hereditary Mixed Polyposis SyndromeThe American Journal of Human Genetics, 2003
- Can resistant starch and/or aspirin prevent the development of coloi neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 StudyProceedings of the Nutrition Society, 2003
- Safety and outcome of endoscopic snare excision of the major duodenal papillaGastrointestinal Endoscopy, 2002
- Pancreas-Preserving Duodenectomy in the Management of Duodenal Familial Adenomatous PolyposisJournal of Gastrointestinal Surgery, 2002
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Transmitting Genetic Risk Information in Families: Attitudes about Disclosing the Identity of RelativesThe American Journal of Human Genetics, 1999
- Causes of Death in Familial Adenomatous PolyposisScandinavian Journal of Gastroenterology, 1999
- Can we safely delay or avoid prophylactic colectomy in familial adenomatous polyposis?British Journal of Surgery, 1996
- Familial Adenomatous PolyposisAnnals of Medicine, 1989